Post COVID-19 conditions: an analysis on fatigue and associated factors
Abstract
Objective: To estimate the prevalence of post-covid-19 fatigue by self-report and analyze the associated factors among residents of the state of Paraíba, Brazil.
Method: This is a cross-sectional study, of the online survey type. Data collection was carried out between March 2023 and March 2024. Descriptive and inferential statistics were performed. Ethical precepts were respected.
Results: A total of 263 participants were included, predominantly female individuals, aged between 21 and 40 years old, who were diagnosed with Covid-19 only once, who classified the acute infection as mild, vaccinated against Covid-19, non-smokers and who consumed alcoholic drinks. The prevalence of self-reported post-covid-19 fatigue was 90.5%. It was found that individuals who reported persistence of symptoms for more than four weeks after infection (OR: 5.55; p=0.000) and those who consumed alcoholic drinks (OR: 2.88, p=0.010) had a higher chance of fatigue.
Conclusions: Fatigue is the most prevalent symptom of post-covid-19 conditions and was associated with persistent symptoms and alcohol consumption.
Keywords: Post-Acute COVID-19 Syndrome; Fatigue; COVID-19; Alcohol consumption.
Downloads
-
Abstract236
-
ESP_PDF (Español (España))106
-
ENG_PDF104
-
XML (Español (España))1
References
National Academies of Sciences, Engineering, and Medicine. A Long COVID definition: A chronic, systemic disease state with profound consequences. Washington, DC: The National Academies Press. 2024. Doi: https://doi.org/10.17226/27768
Hartung TJ, Bahmer T, Chaplinskaya-Sobol I, Deckert J, Endres M, Franzpotter K, et al. Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study. EClinicalMedicine. 2024; 69:102456. Doi: https://doi.org/10.1016/j.eclinm.2024.102456
Luo D, Mei B, Wang Piao, Li X, Chen X, Wei G, et al. Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis. Clin Microbiol Infect. 2024; 30(3):328-35. Doi: https://doi.org/10.1016/j.cmi.2023.10.016
Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol. 2022; 94(1):253-62. Doi: https://doi.org/10.1002/jmv.27309
Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022; 101:93-135. doi: https://doi.org/10.1016/j.bbi.2021.12.020
Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022; 434:120162. Doi: https://doi.org/10.1016/j.jns.2022.120162
Campos MC, Nery T, Starke AC, de Bem Alves AC, Speck AE, S Aguiar A. Post-viral fatigue in COVID-19: A review of symptom assessment methods, mental, cognitive, and physical impairment. Neurosci Biobehav Rev. 2022; 142:104902. Doi: https://doi.org/10.1016/j.neubiorev.2022.104902
Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021; 114(9):428-42. Doi: https://doi.org/10.1177/01410768211032850
Valliant R, Dever J, Kreuter F. Practical Tools for Designing and Weighting Survey Samples. Statistics for Social and Behavioral Sciences. 2013; 51:203-255. Disponível em: https://link.springer.com/chapter/10.1007/978-1-4614-6449-5_9
Miranda DAP, Gomes SVC, Filgueiras PS, Corsini CA, Almeida NBF, Silva RA, et al. Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2022; 116(11). Doi: https://doi.org/10.1093/trstmh/trac030
Cochran WG. Sampling Techniques. 3. ed. John Wiley & Sons: New York; 1977.
Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I. Persistent fatigue and cognitive impairment following COVID-19: a population-based cohort study. Lancet Regional Health Europe. 2022;12:100284. Doi: https://doi.org/10.1016/j.lanepe.2021.100284
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-31. Doi: https://doi.org/10.1038/s41591-021-01292-y
Nehme M, Chappuis F, Kaiser L, Assal F, Guessous I. The Prevalence, Severity, and Impact of Post-COVID Persistent Fatigue, Post-Exertional Malaise, and Chronic Fatigue Syndrome. J Gen Intern Med. 2023;38:835-9. Doi: https://doi.org/10.1007/s11606-022-07882-x
Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784. Doi: https://doi.org/10.1371/journal.pone.0240784
Carfi A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324(6):603-5. Doi: https://doi.org/10.1001/jama.2020.12603
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021; 397(10270):220-32. Doi: https://doi.org/10.1016/S0140-6736(20)32656-8
Goërtz YM, Herck MV, Delbressine JM, Vaes AW, Meys R, Machado FV, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?. ERJ Open Res. 2020;6(4):00542-2020. Doi: https://doi.org/10.1183/23120541.00542-2020
Guarnieri JW, Dybas JM, Fazelinia H, Kim MS, Frere J, Zhang Y, et al. Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Sci Transl Med. 2023;15(708):eabq1533. Doi: https://doi.org/10.1126/scitranslmed.abq1533
Gain C, Song S, Angtuaco T, Satta S and Kelesidis T. The role of oxidative stress in the pathogenesis of infections with coronaviruses. Front Microbiol. 2023; 13(1111930). Doi: https://doi.org/10.3389/fmicb.2022.1111930
Mohandas S, Jagannathan P, Henrich TJ, Xerife ZA, Bime C, Quilan E, et al. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC). eLife. 2023; 12. Doi: https://doi.org/10.7554/eLife.86014
Walker S, Goodfellow H, Pookarnjanamorakot P, Murray E, Bindman J, Blandford A, et al. Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study. BMJ Open. 2023;13. Doi: https://doi.org/10.1136/bmjopen-2022-069217
Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Boubao-Tournois C, Laribi D, et al. Follow-up of adults with non-critical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021; 27(2):258-63. Doi: https://doi.org/10.1016/j.cmi.2020.09.052
Azzam A, Khaled H, Refaey N, Mohsen S, El-Eman AO, Dawood N, et al. The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults. Virol J. 2024; 21:16. Doi: https://doi.org/10.1186/s12985-024-02284-3
Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Medicine. 2023; 2:e000385. Doi: https://doi.org/10.1136/bmjmed-2022-000385
Reardon S. Long COVID risk falls only slightly after vaccination, huge study shows. Nature. 2022. Doi: https://doi.org/10.1038/d41586-022-01453-0
Ledford H. Do vaccines protect against long COVID? What the data say. Nature. 2021; 599(7886):546-8. Doi: https://doi.org/10.1038/d41586-021-03495-2
Malik M, Yagan L, Zakaria D. New onset of acute and chronic hepatic diseases post-COVID-19 infection: a systematic review. Biomedicines. 2024; 12(9):2065. Doi: https://doi.org/10.3390/biomedicines12092065
Logue JK, Franko NM, McCulloch DJ, Mcdonald D, Magedson A, Lobo CR, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021; 4(2). Doi: https://doi.org/10.1001/jamanetworkopen.2021.0830
Copyright (c) 2025 Global Nursing

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.










